Ministerial Opening IP x Venture 2026: Meticuly Showcases Connecting Research to Market Opportunities through its Patient Specific Implant
From 27 to 29 August 2026, Meticuly exhibited in the Health Tech pavilion at IP x Venture (RISE Thailand 2026) at IMPACT Exhibition Hall. Centred on the theme ‘From Innovation to Income’, the summit brought together research institutions, venture capital investors, and state agencies to accelerate the commercialisation of intellectual property (IP) across key national industries.
Ministerial Opening: Bridging Innovation and Capital
The summit was officially opened through a joint initiative between two key ministries, presided over by:
Mrs Suphajee Suthumpun, Deputy Prime Minister and Minister of Commerce.
Assoc. Prof. Dr Yodchanan Wongsawat, Deputy Prime Minister and Minister of Higher Education, Science, Research and Innovation (MHESI).
The opening remarks by Assoc. Prof. Dr. Yodchanan Wongsawat stressed the urgency of connecting university research directly to private-sector capital and market opportunities. Protecting domestic intellectual property and building local manufacturing capabilities were highlighted as essential steps toward reducing national reliance on foreign technology, particularly within high-value sectors such as Health Tech.
Key Discussion Sessions: Unlocking IP Value and Health Tech Growth
The three-day forum featured targeted panel discussions addressing how intellectual property transforms academic research into scalable commercial assets:
IP as a Key Business Enabler: Industry experts discussed how protecting technical IP serves as a foundation for securing venture investment and expanding market reach for deep-tech enterprises.
From Lab to Longevity: The Future of Wellness and HealthTech: Panellists explored the convergence of preventative medicine, clinical research, and local manufacturing to support long-term healthcare sustainability.
Power Connect: Ecosystem to Accelerate Research Utilisation: Leaders across government, academia, and industry examined policy frameworks and supply chain integration needed to transition lab discoveries into active clinical use.
Within this framework, Meticuly demonstrated a practical case study of translating metallurgical research into ISO-certified, patient-matched surgical solutions.
Key Discussion Highlights: IP Commercialisation & Public Impact
National Import Substitution: Decreasing surgical costs and foreign currency expenditure by replacing imported, standard implants with homegrown solutions.
Surgical Access: Enabling local hospitals to utilise biocompatible 3D printing technology engineered specifically for complex anatomical defects.
Social Innovation for National Healthcare Sustainability with Patient Specific Implant
Retaining advanced medical IP within the country delivers direct economic and societal benefits. Local manufacturing of Patient-Specific Implant devices minimises vulnerability to global supply chain disruptions while lowering the overall financial burden on public healthcare systems.
Securing patents for medical-grade 3D printing provides a foundation for domestic healthcare self-reliance. By translating protected research into accessible clinical tools, Meticuly continues to support surgical precision and improve patient outcomes across both public and private healthcare networks.
Through its participation at IP x Venture 2026, Meticuly reaffirmed its commitment to turning deep-tech research into practical healthcare solutions, setting a benchmark for sustainable medical technology across the region.
Comments